<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medvis</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская визуализация</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Visualization</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-0763</issn><issn pub-type="epub">2408-9516</issn><publisher><publisher-name>RDS-Media Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24835/1607-0763-1357</article-id><article-id custom-type="elpub" pub-id-type="custom">medvis-1357</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТЕХНОЛОГИИ ЛУЧЕВОЙ ДИАГНОСТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RADIOLOGICAL TECHNOLOGIES</subject></subj-group></article-categories><title-group><article-title>Показатели МСКТ и МРТ для оценки перегрузки железом и эффективности терапии перегрузки железом у пациентов с первичными и вторичными гемохроматозами</article-title><trans-title-group xml:lang="en"><trans-title>MSCT and MRI indicators for assessing iron overload and the effectiveness of iron overload therapy in patients with primary and secondary hemochromatoses</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6605-0663</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Titova</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Титова Анна Михайловна – врач-рентгенолог отделения лучевой диагностики №1 ФГБУ “НМИЦ им. В.А. Алмазова” Минздрава России; инженер физического факультета ФГАОУ ВО “Национальный исследовательский университет ИТМО”</p><p>тел.: +7-962-721-51-80</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2197101 Санкт-Петербург, Кронверкский пр., д. 49, лит. А</p></bio><bio xml:lang="en"><p>Anna M. Titova – radiologist of the Department of Radiation Diagnostics No. 1 of the Almazov National Research Medical Center; Physics Faculty Engineer of ITMO University</p><p>phone: +7-962-721-51-80</p><p>2, Akkuratova str., St.-Petersburg 19734149-A, Kronverksky prosp., St.-Petersburg 197101</p></bio><email xlink:type="simple">anisa33@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2937-6322</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фокин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fokin</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фокин Владимир Александрович – доктор мед. наук, профессор кафедры лучевой диагностики и медицинской визуализации ФГБУ “НМИЦ им. В.А. Алмазова” Минздрава России; ФГАОУ ВО “Национальный исследовательский университет ИТМО”</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2197101 Санкт-Петербург, Кронверкский пр., д. 49, лит. А</p></bio><bio xml:lang="en"><p>Vladimir A. Fokin – Doct. of Sci. (Med.), Professor of the Department of Radiation Diagnostics and Medical Imaging of the Almazov National Research Medical Center; Senior Researcher of ITMO University</p><p>2, Akkuratova str., St.-Petersburg 19734149-A, Kronverksky prosp., St.-Petersburg 197101</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1611-5000</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Труфанов</surname><given-names>Г. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Trufanov</surname><given-names>G. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Труфанов Геннадий Евгеньевич – доктор мед. наук, профессор, заведующий НИО лучевой диагностики, заведующий кафедрой лучевой диагностики и медицинской визуализации ФГБУ “НМИЦ им. В.А. Алмазова” Минздрава России; ведущий научный сотрудник Университета ИТМО</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2197101 Санкт-Петербург, Кронверкский пр., д. 49, лит. А</p></bio><bio xml:lang="en"><p>Gennady E. Trufanov – Doct. of Sci. (Med.), Professor, Head of the Research Institute of Radiation Diagnostics, Head of the Department of Radiation Diagnostics and Medical Imaging of the Almazov National Research Medical Center; Senior Researcher of ITMO University</p><p>2, Akkuratova str., St.-Petersburg 19734149-A, Kronverksky prosp., St.-Petersburg 197101</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0768-1737</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубков</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubkov</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зубков Михаил Александрович – PhD, старший научный сотрудник физического факультета</p><p>197101 Санкт-Петербург, Кронверкский пр., д. 49, лит. А</p></bio><bio xml:lang="en"><p>Mikhail A. Zubkov – PhD, Assistant Professor</p><p>49-A, Kronverksky prosp., St.-Petersburg 197101</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7909-6452</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitina</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никитина Анна Владиславовна – врач-рентгенолог отделения лучевой диагностики №1</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Anna V. Nikitina – radiologist of the Department of Radiation Diagnostics No. 1</p><p>2, Akkuratova str., St.-Petersburg 197341</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8138-666X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мирончук</surname><given-names>Р. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironchuk</surname><given-names>R. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мирончук Ростислав Ростиславович – врач-рентгенолог отделения лучевой диагностики №1</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Rostislav R. Mironchuk – radiologist of the Department of Radiation Diagnostics No. 1</p><p>2, Akkuratova str., St.-Petersburg 197341</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8138-666X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мирончук</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironchuk</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мирончук Мария Викторовна – врач-рентгенолог отделения лучевой диагностики №1</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Maria V. Mironchuk – radiologist of the Department of Radiation Diagnostics No. 1</p><p>2, Akkuratova str., St.-Petersburg 197341</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5751-6604</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цветкова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsvetkova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цветкова Надежда Васильевна – клинический ординатор кафедры лучевой диагностики и медицинской визуализации ИМО</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Nadezhda V. Tsvetkova – clinical resident of Radiation Diagnostics and Medical Imaging</p><p>2, Akkuratova str., St.-Petersburg 197341</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5000-3582</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шалыгина</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Shalygina</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шалыгина Ксения Сергеевна – клинический ординатор кафедры лучевой диагностики и медицинской визуализации ИМО</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Ksenia S. Shalygina – clinical resident of Radiation Diagnostics and Medical Imaging</p><p>2, Akkuratova str., St.-Petersburg 197341</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5607-8550</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галяутдинова</surname><given-names>Л. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Galyautdinova</surname><given-names>L. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галяутдинова Лина Эриковна – клинический ординатор кафедры лучевой диагностики и медицинской визуализации ИМО</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Lina E. Galyautdinova – clinical resident of Radiation Diagnostics and Medical Imaging</p><p>2, Akkuratova str., St.-Petersburg 197341</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5008-954X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукин</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukin</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лукин Максим Владимирович – клинический ординатор кафедры лучевой диагностики и медицинской визуализации ИМО</p><p>197341 Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Maksim V. Lukin – clinical resident of Radiation Diagnostics and Medical Imaging</p><p>2, Akkuratova str., St.-Petersburg 197341</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-0537-991X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бадриева</surname><given-names>З. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Badrieva</surname><given-names>Z. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бадриева Зиля Фирдинасовна – инженер физического факультета</p><p>197101 Санкт-Петербург, Кронверкский пр., д. 49, лит. А</p></bio><bio xml:lang="en"><p>Zilya F. Badrieva – engineer</p><p>49-A, Kronverksky prosp., St.-Petersburg 197101</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ “Национальный медицинский исследовательский центр им. В.А. Алмазова” Минздрава России; ФГАОУ ВО “Национальный исследовательский университет ИТМО”</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre; ITMO University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО “Национальный исследовательский университет ИТМО”</institution><country>Россия</country></aff><aff xml:lang="en"><institution>ITMO University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ “Национальный медицинский исследовательский центр им. В.А. Алмазова” Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>03</day><month>11</month><year>2023</year></pub-date><volume>27</volume><issue>4</issue><fpage>170</fpage><lpage>178</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Титова А.М., Фокин В.А., Труфанов Г.Е., Зубков М.А., Никитина А.В., Мирончук Р.Р., Мирончук М.В., Цветкова Н.В., Шалыгина К.С., Галяутдинова Л.Э., Лукин М.В., Бадриева З.Ф., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Титова А.М., Фокин В.А., Труфанов Г.Е., Зубков М.А., Никитина А.В., Мирончук Р.Р., Мирончук М.В., Цветкова Н.В., Шалыгина К.С., Галяутдинова Л.Э., Лукин М.В., Бадриева З.Ф.</copyright-holder><copyright-holder xml:lang="en">Titova A.M., Fokin V.A., Trufanov G.E., Zubkov M.A., Nikitina A.V., Mironchuk R.R., Mironchuk M.V., Tsvetkova N.V., Shalygina K.S., Galyautdinova L.E., Lukin M.V., Badrieva Z.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://medvis.rdsmedia.ru/jour/article/view/1357">https://medvis.rdsmedia.ru/jour/article/view/1357</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: оценка параметров МРТ, МСКТ после проведения хелаторной, а также гемоэксфузионной терапии у пациентов с перегрузкой железа, выявление прогностической ценности показателей МСКТ в оценке среднетяжелой и тяжелой перегрузки железом.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Дизайн исследования – проспективное. В исследование включено 43 пациента с первичным (наследственным) гемохроматозом (НГХ) и вторичным трансфузионно-зависимым гемохроматозом (ВГ), получающих регулярные гемотрансфузии и терапию хелаторами железа. Проведена оценка возраста, частоты переливаний крови, используемого хелатирующего препарата. МСКТ выполнялась на двухэнергетическом компьютерном томографе Siemens Somatom Definition 128. До повторной МСКТ дошли 27 (62,8%) пациентов. МРТ проводили на высокопольном томографе Siemens Magnetom Espee с индукцией магнитного поля 1,5 Тл.</p></sec><sec><title>Результаты</title><p>Результаты. Медиана возраста – 34,00 [33,00; 53,50] года для НГХ и 52 [36,00; 62,00] года для ВГ. После терапии в общей группе значения T2* увеличились на 26%, LIC снизилась на 21,2%, ДЭРHU 140 и 80 mean на 17,6%, ДЭОHU 140 и 80 mean на 3%, ДЭИHU 140 и 80 mean на 92,8%, 80 max на 3%, ДЭРHU 140 и 80 max на 19%, ДЭО HU 140 и 80 max на 2,5% после терапии. У пациентов с НГХ Т2* печени увеличилось в 4,6 раза, LIC снизилась в 5,5 раза, ДЭРHU 140 и 80 mean на 35,1%, ДЭОHU 140 и 80 mean на 7,8%, ДЭИHU 140 и 80 mean на 93,6%, ДЭРHU 140 и 80 max на 29,3%, ДЭИHU 140 и 80 max на 21.6%. У пациентов ВГ LIC снизилась на 18,9%, ДЭИHU 140 и 80 mean на 92,2%. Значение 80 mean ≥ 85,5, значение 140 mean ≥ 71,5, значение М0,3 mean ≥ 76, значение ДЭИHU 140 и 80 mean ≥ 0,007996 и значение ДЭРHU 140 и 80 mean ≥ 18,5 предсказывают вероятность тяжелой перегрузки железом.</p></sec><sec><title>Заключение</title><p>Заключение. У пациентов после проведенной хелаторной терапии и терапии гемоэксфузиями снижаются показатели МРТ и МСКТ. Значения МСКТ 80 mean ≥ 85,5, 140 mean ≥ 71,5, М0,3 mean ≥ 76, ДЭИHU 140 и 80 mean ≥ 0,007996, ДЭРHU 140 и 80 mean ≥ 18,5 могут предсказывать значения LIC более 11 мг/г.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Goal of research</title><p>Goal of research. Evaluation of MRI, CT parameters after chelation and hemoexfusion therapy in patients with iron overload, identification of the prognostic value of CT indicators in the assessment of moderate and severe iron overload.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The design of the study is prospective. The study included 43 patients with hereditary hemochromatosis (HH), secondary transfusion-dependent hemochromatosis (TDH) receiving regular hemotransfusions, iron chelators. We evaluated age, frequency of hemotransfusions, chelating drug used. CT was performed on a two-energy computer tomograph Siemens Somatom Definition 128. 27 patients (62.8%) reached repeated CT. MRI was performed on a Siemens Magnetom Espee high-field tomograph with a magnetic field induction of 1.5 T.</p></sec><sec><title>Results</title><p>Results. The median age was 34.00 [33.00; 53.50] for HH and 52 [36.00; 62.00] for TDH. After therapy in the general group, T2* values increased by 26%, LIC decreased by 21.2%, DEDHU 140 and 80 mean by 17.6%, DERHU 140 and 80 mean by 3%, DEIHU 140 and 80 mean by 92.8%, 80 max by 3%, DEDHU 140 and 80 max by 19%, DERHU 140 and 80 max by 2.5% after therapy. In patients with HH, liver T2* increased by 4.6 times, LIC decreased by 5.5 times, DEDHU 140 and 80 mean by 35.1%, DERHU 140 and 80 mean by 7.8%, DEIHU 140 and 80 mean by 93.6%, DEDHU 140 and 80 max by 29.3%, DEIHU 140 and 80 max by 21.6%. In patients with TDH, LIC decreased by 18.9%, DEIHU 140 and 80 mean by 92.2%. A value of 80 mean ≥ 85.5, 140 mean ≥ 71.5, M0.3 mean ≥ 76, DEIHU 140 and 80 mean ≥ 0.007996 and DEDHU 140 and 80 mean ≥ 18.5 predict the probability of severe iron overload.</p></sec><sec><title>Conclusion</title><p>Conclusion. In patients after chelation therapy and hemoexfusion therapy, MRI and CT indicators decrease. The values of CT 80 mean ≥ 85.5, 140 mean ≥ 71.5, M0.3 mean ≥ 76, DEIHU 140 and 80 mean ≥ 0.007996, DEDHU 140 and 80 mean ≥ 18.5 can predict LIC values of more than 11 mg/g.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>LIC</kwd><kwd>ДЭИ</kwd><kwd>ДЭО</kwd><kwd>ДЭР</kwd><kwd>гемохроматоз</kwd><kwd>МСКТ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>LIC</kwd><kwd>DEI</kwd><kwd>DER</kwd><kwd>DED</kwd><kwd>hemochromatosis</kwd><kwd>CT</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке Министерства науки и высшего образования Российской Федерации (проект № 075-15-2021-592).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson L.J., Holden S., Davis B. et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 2001; 22 (23): 2171–2179. http://doi.org/10.1053/euhj.2001.2822</mixed-citation><mixed-citation xml:lang="en">Anderson L.J., Holden S., Davis B. et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 2001; 22 (23): 2171–2179. http://doi.org/10.1053/euhj.2001.2822</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zachrisson H., Engstrom E., Engvall J. et al. Soft tissue discrimination ex vivo by dual energy computed tomography. Eur. J. Radiol. 2010; 75: e124–e128.</mixed-citation><mixed-citation xml:lang="en">Zachrisson H., Engstrom E., Engvall J. et al. Soft tissue discrimination ex vivo by dual energy computed tomography. Eur. J. Radiol. 2010; 75: e124–e128.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer M.A., Gnannt R., Raptis D. et al. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest. Radiol. 2011; 46 (6): 351–358. http://doi.org/10.1097/RLI.0b013e31820e1486</mixed-citation><mixed-citation xml:lang="en">Fischer M.A., Gnannt R., Raptis D. et al. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest. Radiol. 2011; 46 (6): 351–358. http://doi.org/10.1097/RLI.0b013e31820e1486</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Patel T., Kozakowski K., Hruby G., Gupta M. Skin to stone distance is an independent predictor of stone-free status following shockwave lithotripsy. J. Endourol. 2009; 23 (9): 1383–1385. http://doi.org/10.1089/end.2009.0394</mixed-citation><mixed-citation xml:lang="en">Patel T., Kozakowski K., Hruby G., Gupta M. Skin to stone distance is an independent predictor of stone-free status following shockwave lithotripsy. J. Endourol. 2009; 23 (9): 1383–1385. http://doi.org/10.1089/end.2009.0394</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Primak A.N., Ramirez Giraldo J.C., Liu X. et al. Improved dual-energy material discrimination for dual-source CT by means of additional spectral filtration. Med. Phys. 2009; 36 (4): 1359–1369.</mixed-citation><mixed-citation xml:lang="en">Primak A.N., Ramirez Giraldo J.C., Liu X. et al. Improved dual-energy material discrimination for dual-source CT by means of additional spectral filtration. Med. Phys. 2009; 36 (4): 1359–1369.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Garbowski M.W., Carpenter J.P., Smith G. et al. Biopsybased calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J. Cardiovasc. Magn. Reson. 2014; 16 (1): 40. http://doi.org/10.1186/1532-429X-16-40</mixed-citation><mixed-citation xml:lang="en">Garbowski M.W., Carpenter J.P., Smith G. et al. Biopsybased calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J. Cardiovasc. Magn. Reson. 2014; 16 (1): 40. http://doi.org/10.1186/1532-429X-16-40</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Vitrano A., Sacco M., Rosso R. et al. Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET. Eur. J. Haematol. 2018; 100 (2): 124–130. http://doi.org/10.1111/ejh.12989</mixed-citation><mixed-citation xml:lang="en">Vitrano A., Sacco M., Rosso R. et al. Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET. Eur. J. Haematol. 2018; 100 (2): 124–130. http://doi.org/10.1111/ejh.12989</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kohgo Y., Urabe A., Kilinç Y. et al. Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias. Acta Haematol. 2015; 134 (4): 233–242. http://doi.org/10.1159/000381893</mixed-citation><mixed-citation xml:lang="en">Kohgo Y., Urabe A., Kilinç Y. et al. Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias. Acta Haematol. 2015; 134 (4): 233–242. http://doi.org/10.1159/000381893</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wood J.C., Mo A., Gera A. et al. Quantitative computed tomography assessment of transfusional iron overload. Br. J. Haematol. 2011; 153 (6): 780–785. http://doi.org/10.1111/j.1365-2141.2011.08590.x</mixed-citation><mixed-citation xml:lang="en">Wood J.C., Mo A., Gera A. et al. Quantitative computed tomography assessment of transfusional iron overload. Br. J. Haematol. 2011; 153 (6): 780–785. http://doi.org/10.1111/j.1365-2141.2011.08590.x</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen P., Engelhardt R., Fischer R. et al. Noninvasive liver-iron quantification by computed tomography in ironoverloaded rats. Invest. Radiol. 1992; 27 (4): 312–317. http://doi.org/10.1097/00004424-199204000-00012</mixed-citation><mixed-citation xml:lang="en">Nielsen P., Engelhardt R., Fischer R. et al. Noninvasive liver-iron quantification by computed tomography in ironoverloaded rats. Invest. Radiol. 1992; 27 (4): 312–317. http://doi.org/10.1097/00004424-199204000-00012</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Peng Y., Ye J., Liu C. et al. Simultaneous hepatic iron and fat quantification with dual-energy CT in a rabbit model of coexisting iron and fat. Quant. Imaging Med. Surg. 2021; 11 (5): 2001–2012. http://doi.org/10.21037/qims-20-902</mixed-citation><mixed-citation xml:lang="en">Peng Y., Ye J., Liu C. et al. Simultaneous hepatic iron and fat quantification with dual-energy CT in a rabbit model of coexisting iron and fat. Quant. Imaging Med. Surg. 2021; 11 (5): 2001–2012. http://doi.org/10.21037/qims-20-902</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tsurusaki M., Sofue K., Hori M. et al. Dual-Energy Computed Tomography of the Liver: Uses in Clinical Practices and Applications. Diagnostics (Basel). 2021; 11 (2): 161. http://doi.org/10.3390/diagnostics11020161</mixed-citation><mixed-citation xml:lang="en">Tsurusaki M., Sofue K., Hori M. et al. Dual-Energy Computed Tomography of the Liver: Uses in Clinical Practices and Applications. Diagnostics (Basel). 2021; 11 (2): 161. http://doi.org/10.3390/diagnostics11020161</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer M.A., Reiner C.S., Raptis D. et al. Quantification of liver iron content with CT-added value of dual-energy. Eur. Radiol. 2011; 21 (8): 1727–1732. http://doi.org/10.1007/s00330-011-2119-1</mixed-citation><mixed-citation xml:lang="en">Fischer M.A., Reiner C.S., Raptis D. et al. Quantification of liver iron content with CT-added value of dual-energy. Eur. Radiol. 2011; 21 (8): 1727–1732. http://doi.org/10.1007/s00330-011-2119-1</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer M.A., Gnannt R., Raptis D. et al. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest. Radiol. 2011; 46 (6): 351–358. http://doi.org/10.1097/RLI.0b013e31820e1486</mixed-citation><mixed-citation xml:lang="en">Fischer M.A., Gnannt R., Raptis D. et al. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest. Radiol. 2011; 46 (6): 351–358. http://doi.org/10.1097/RLI.0b013e31820e1486</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Werner S., Krauss B., Haberland U. et al. Dual-energy CT for liver iron quantification in patients with haematological disorders. Eur. Radiol. 2019; 29 (6): 2868–2877. http://doi.org/10.1007/s00330-018-5785-4</mixed-citation><mixed-citation xml:lang="en">Werner S., Krauss B., Haberland U. et al. Dual-energy CT for liver iron quantification in patients with haematological disorders. Eur. Radiol. 2019; 29 (6): 2868–2877. http://doi.org/10.1007/s00330-018-5785-4</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
